Cargando…
Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure
BACKGROUND: Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart failure (HF) would allow targeted intervention, and appears to be the most promising approach in its management. Novel biomarker panels may support this approach and provide new insights into the pathoph...
Autores principales: | Zhang, Zhen‐Yu, Ravassa, Susana, Nkuipou‐Kenfack, Esther, Yang, Wen‐Yi, Kerr, Shona M., Koeck, Thomas, Campbell, Archie, Kuznetsova, Tatiana, Mischak, Harald, Padmanabhan, Sandosh, Dominiczak, Anna F., Delles, Christian, Staessen, Jan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586413/ https://www.ncbi.nlm.nih.gov/pubmed/28784649 http://dx.doi.org/10.1161/JAHA.116.005432 |
Ejemplares similares
-
Urinary Peptidomic Biomarker for Personalized Prevention and Treatment of Diastolic Left Ventricular Dysfunction
por: Zhang, Zhen‐Yu, et al.
Publicado: (2019) -
Epidemiologic observations guiding clinical application of a urinary peptidomic marker of diastolic left ventricular dysfunction
por: Zhang, Zhen-Yu, et al.
Publicado: (2018) -
Urinary peptidomic biomarkers of renal function in heart transplant recipients
por: Huang, Qi-Fang, et al.
Publicado: (2019) -
Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction
por: Rossing, Kasper, et al.
Publicado: (2016) -
The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
por: Campbell, Ross T., et al.
Publicado: (2020)